Latin America Allergy Diagnostics Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 4.25 Billion |
 Market Size (Forecast Year) |
USD 9.72 Billion |
 CAGR |
% |
| Major Markets Players |
Latin America Allergy Diagnostics Market, By Products and Services (Assay Kits, Instruments, Consumables and Services), Allergen (Inhaled Allergens, Food Allergens, Antibiotics, Other Drugs and Chemicals Allergens, Occupational Allergens, Miscellaneous Plant Allergens, Contact Allergens And Others), Test (In-Vitro Test and In-Vivo Test), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories and Others), Distribution Channel (Direct and Indirect) – Industry Trends and Forecast to 2029
Market Analysis and Size
According to the WHO (World Health Organization), nearly 80% of the world's population lives in cities, and as a result, air quality has a substantial impact on them, mainly in low-income nations. In addition, multiple studies have linked air pollution to allergic rhinitis, asthma, and other disorders, leading to an increase in allergy diagnoses. Although allergies can affect practically every organ in the body and can be triggered by a variety of external causes, there are a few common themes that should be highlighted in research efforts. Effective prevention, curative therapy, and accurate, early diagnosis, as with many other chronic diseases, are key unmet requirements. In order to organise or re-categorize clinical symptoms into more coherent, consistent, and treatment-responsive groupings, detailed phenotyping/endotyping is widely required.
Data Bridge Market Research analyses that the Latin America allergy diagnostics market which was USD 4.25 billion in 2021, would rocket up to USD 9.72 billion by 2029, and is expected to undergo a CAGR of 10.9% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Products and Services (Assay Kits, Instruments, Consumables and Services), Allergen (Inhaled Allergens, Food Allergens, Antibiotics, Other Drugs and Chemicals Allergens, Occupational Allergens, Miscellaneous Plant Allergens, Contact Allergens And Others), Test (In-Vitro Test and In-Vivo Test), End User (Hospitals, Diagnostic Laboratories, Academic Research Laboratories and Others), Distribution Channel (Direct and Indirect) |
|
Countries Covered |
Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Thermo Fisher Scientific Inc., (US), Siemens Healthcare GmbH (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK) |
|
Market Opportunities |
|
Market Definition
Allergies affect nearly every organ in the body in a variety of ways, with a wide range of symptoms, and hence their manifestations span a vast range of phenotypes. According to studies in Europe, up to 30% of the population suffers from allergic rhino conjunctivitis, 20% suffer from asthma, and 15% suffer from allergic skin diseases. Food allergies are growing more common and severe; occupational allergies, medication allergies, and insect sting allergies (which can be lethal) contribute to the allergy epidemic.
Latin America Allergy Diagnostics Market Dynamics
Drivers
- Increasing environmental pollution levels
Exposure to indoor and outdoor air pollution, allergies, and occupational exposure are the key risk factors for chronic respiratory illnesses. The prevalence of allergy diseases is higher in city dwellers than in rural people due to the higher exposure to environmental contaminants in cities (as a result of vehicular pollution and industrial activities). More than 80% of people living in cities are exposed to air quality levels that exceed WHO safety recommendations, according to the WHO; while this is a global trend, the implications are particularly severe in low-income countries' urban zones. This is a key indicator of the market's expansion in allergy diagnostics.
- Growing environmental pollution levels
The primary drivers of growth are rising healthcare expenditures and average lifespans, increased understanding of preventative testing, improved diagnostic test offerings, rising lifestyle-related diseases, and government-mandated healthcare treatments.
- Increase in the access to health insurance
The market is dominated by large hospitals and diagnostic laboratories, which can afford high-volume systems due to their large capital budgets. Rising healthcare expenditures aid the expansion of the allergy diagnostics market as a result of high healthcare service costs. In addition, governments in many countries are giving reimbursements and healthcare insurance programmes to boost consumer demand for allergy diagnostics around the world.
Opportunities
- Use of mHealth in allergy diagnosis
With only a few mHealth tools for allergic rhinitis (AR) diagnosis published in peer-reviewed papers, the use of mHealth for rhinitis diagnosis is currently limited. A new breed of point-of-care devices has emerged as a result of recent advancements in integrated biosensors, wireless connectivity, and power harvesting techniques. AR, on the other hand, is a highly prevalent disease. Any diagnostic gadget connected to a smartphone (e.g., peak nasal inspiratory flow metres or intranasal biosensors) would have to be affordable.
Restraints/Challenges
- Difficulty in allergy diagnosis
The difficulty in allergy diagnosis is coming up with procedures that are objective, quick, repeatable, cost-effective, sensitive, and specific to the condition. They must be able to recognise exposures and contribute to therapeutic decision-making, preferably in primary care. In addition, tests to monitor therapy response and to compare preclinical and clinical effects across large cohorts and between nations are required.
- Premium costs associated with allergy diagnostic instruments
Market participants update several allergy diagnostic devices, including as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers, on a regular basis. These instruments are more expensive since they have more advanced features and functions (the price of each instrument varies based on its accuracy, flexibility, and TAT). Immunoassay analyzers, for example, cost between USD 10,000 and USD 20,000, while luminometers cost between USD 3,000 and USD 14,000. ELISA readers that are semi-automated cost between USD 2,000 and USD 5,000, while fully automated analyzers cost over USD 14,000. In addition, operating this equipment necessitates extra costs such as maintenance and insurance, laboratory supervision, and overheads (such as utilities, space, and administration).
This Latin America allergy diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Latin America allergy diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Latin America Allergy Diagnostics Market
COVID 19 has been the subject of several research to see how it affects allergy diagnostic testing services. According to a survey done in Turkey, allergists prefer to employ telemedicine for asthma and rhinitis during the COVID-19 outbreak at a high rate. However, face-to-face interviews were preferable for more severe allergic illnesses like anaphylaxis and hereditary angioedema. Other countries, such as Italy and the United States, have seen a similar trend. In Australia, face-to-face consultations in outpatient clinics were confined to urgent patients with rheumatological disorders, and roughly 80% of outpatient visits were switched to telemedicine. This also hampered the market's expansion by limiting the restriction and decrease of various diagnostic and treatment services.
Recent Development
- In 2021, Hitachi Chemical Diagnostics, Inc. has been replaced by Minaris Medical America, Inc. By uniting the medical business group firms under the Minaris Medical brand, Hitachi wants to boost its global position and increase commercial activities in the field of in-vitro diagnostics. Both companies are owned by Showa Denko Materials Co., Ltd.
- In 2021, PerkinElmer Inc. has reached an agreement to purchase Immunodiagnostic Systems Holdings PLC. PerkinElmer Inc. will be able to strengthen its position in the ImmunoDiagnostics (IDS) industry as a result of the acquisition. EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a firm that sells allergy products and services, will take over IDS.
Latin America Allergy Diagnostics Market Scope
The Latin America allergy diagnostics market is segmented on the basis of product, allergan, test, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Assay Kits
- Consumables
- Instruments
- Immunoassay Analyzers
- ELISA Analyzers
- Luminometers
- Other Instruments
- Services
Allergen
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Other Allergens
Test
- In Vivo Tests
- Skin Prick Tests
- Patch Tests
- Other In Vivo Tests
- In Vitro Tests
End User
- Diagnostic Laboratories
- Hospital-based Laboratories
- Academic Research Institutes
- Other End Users
Distribution Channel
- Direct
- Indirect
Latin America Allergy Diagnostics Market Regional Analysis/Insights
The Latin America allergy diagnostics market is analysed and market size insights and trends are provided by country, product, allergan, test, end-user and distribution channel as referenced above.
The countries covered in the Latin America allergy diagnostics market report are Brazil, Argentina and Rest of South America as part of South America.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Latin America allergy diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Latin America allergy diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Latin America allergy diagnostics market. The data is available for historic period 2010-2020.
Competitive Landscape and Latin America Allergy Diagnostics Market Share Analysis
The Latin America allergy diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Latin America allergy diagnostics market.
Some of the major players operating in the Latin America allergy diagnostics market are:
- Thermo Fisher Scientific Inc., (US)
- Siemens Healthcare GmbH (Germany)
- Danaher (US)
- Omega Diagnostics Group PLC (UK)
- bioMérieux (France)
- Romer Labs Division Holding (Austria)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- HollisterStier Allergy (US)
- NEOGEN Corporation (US)
- Eurofins Scientific (Luxembourg)
- Minaris Medical America, Inc. (US)
- Stallergenes Greer (UK)
- HOB Biotech Group Corp., Ltd. (China)
- HYCOR Biomedical (US)
- R-Biopharm AG (Germany)
- AESKU.GROUP GmbH (Germany)
- ACON Laboratories, Inc. (US)
- Lincoln Diagnostics, Inc. (US)
- Astra Biotech GmbH (Germany)
- Erba Group (UK)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF LATAM ALLERGY DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 PRODUCT TIMELINE CURVE
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING ENVIRONMENTAL POLLUTION LEVELS
3.1.2 HIGH INCIDENCE OF ALLERGIC DISEASES
3.1.3 INCREASING HEALTHCARE EXPENDITURE
3.2 RESTRAINTS
3.2.1 LACK AWARENESS OF ALLERGY DISEASES
3.2.2 HIGH COST OF ALLERGY TEST, TESTING KITS AND DIAGNOSTICS PRODUCT
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGY ADVANCEMENT
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.4 CHALLENGES
3.4.1 LACK OF SKILLED PROFESSIONALS
3.4.2 STRICT REGULATORY POLICY
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 ASSAY KITS
6.2.1 ELISA KITS
6.2.2 AGRASTRIP
6.2.3 RAPID TEST EASY KIT
6.2.4 OTHERS
6.3 INSTRUMENTS
6.3.1 ELISA ANALYZERS
6.3.2 IMMUNOASSAY ANALYZERS
6.3.3 LATERAL FLOW DEVICES
6.3.4 LUMINOMETERS
6.3.5 OTHERS
6.4 CONSUMABLES
6.5 SERVICES
7 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN
7.1 OVERVIEW
7.2 ANTIBIOTICS, OTHER DRUGS AND CHEMICALS ALLERGENS
7.3 FOOD ALLERGENS
7.4 INHALED ALLERGENS
7.5 OCCUPATIONAL ALLERGENS
7.6 CONTACT ALLERGENS
7.7 MISCELLANEOUS PLANT ALLERGENS
7.8 OTHERS
8 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST
8.1 OVERVIEW
8.2 IN-VIVO TEST
8.2.1 BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST)
8.2.1.1 TOTAL IGE
8.2.1.2 CAST TESTING/ SPECIFIC IGE
8.2.2 MULTI-ALLERGEN IGE ANTIBODY SCREENING ASSAYS
8.2.3 MAST CELL TRYPTASE
8.2.4 OTHERS
8.3 IN-VITRO TEST
8.3.1 SKIN-PRICK TESTING
8.3.2 INTRADERMAL SKIN TESTS
8.3.3 SCRATCH TEST
8.3.4 OTHERS
9 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC LABORATORIES
9.3 HOSPITALS
9.4 ACADEMIC RESEARCH LABORATORIES
9.5 OTHERS
10 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT
10.3 INDIRECT
11 LATAM, ALLERGY DIAGNOSTICS MARKET GEOGRAPHY
11.1 LATAM
1.1.1. MEXICO
1.1.2. BRAZIL
1.1.3. ARGENTINA
1.1.4. CHILE
1.1.5. URUGUAY
1.1.6. PERU
1.1.7. COLOMBIA
1.1.8. ECUADOR
1.1.9. REST OF LATAM
12 LATAM ALLERGY DIAGNOSTICS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: LATAM
13 COMPANY PROFILE
13.1 OMEGA DIAGNOSTICS GROUP PLC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 SIEMENS HEALTHINEERS AG
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 R-BIOPHARM AG
13.3.1 COMPANY SNAPSHOT
13.3.2 PRODUCT PORTFOLIO
13.3.3 RECENT DEVELOPMENT
13.4 THERMO FISHER SCIENTIFIC INC
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 PERKINELMER INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 BIOMÉRIEUX SA
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 RECENT DEVELOPMENT
13.7 HITACHI, LTD
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 INDOOR BIOTECHNOLOGIES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 SERVICE PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 QUEST DIAGNOSTICS INCORPORATED
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 ROXALL MEDIZIN GMBH
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 COST OF ASSEY KITS.
TABLE 2 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 3 LATAM, MENA, , INDIA ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 4 LATAM ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 5 LATAM INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 LATAM INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 7 LATAM CONSUMABLES IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 LATAM SERVICES IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 9 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 10 LATAM ANTIBIOTICS, OTHER DRUGS AND CHEMICALS ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 LATAM FOOD ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 LATAM INHALED ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 LATAM OCCUPATIONAL ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 14 LATAM CONTACT ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 LATAM MISCELLANEOUS PLANT ALLERGENS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 16 LATAM OTHERS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 18 LATAM IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 LATAM IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 20 LATAM BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 21 LATAM IN- VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 LATAM IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 23 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 24 LATAM DIAGNOSTIC LABORATORIES IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 LATAM HOSPITALS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 LATAM ACADEMIC RESEARCH LABORATORIES IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 27 LATAM OTHERS IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 29 LATAM DIRECT IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 LATAM INDIRECT IN ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 31 LATAM ALLERGY DIAGNOSTICS MARKET, BY REGION, 2018 – 2027 (USD MILLION)
TABLE 32 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 33 LATAM ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 34 LATAM INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 35 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 36 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 37 LATAM IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 38 LATAM BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 39 LATAM IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 40 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER ,2018-2027 (USD MILLION)
TABLE 41 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 42 MEXICO ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 43 MEXICO ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 44 MEXICO INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 45 MEXICO ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 46 MEXICO ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 47 MEXICO IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 48 MEXICO BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 49 MEXICO IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 50 MEXICO ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 51 MEXICO ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 52 BRAZIL ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 53 BRAZIL ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 54 BRAZIL INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 55 BRAZIL ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 56 BRAZIL ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 57 BRAZIL IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 58 BRAZIL BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 59 BRAZIL IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 60 BRAZIL ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 61 BRAZIL ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 62 ARGENTINA ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 63 ARGENTINA ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 64 ARGENTINA INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 65 ARGENTINA ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 66 ARGENTINA ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 67 ARGENTINA IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 68 ARGENTINA BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 69 ARGENTINA IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 70 ARGENTINA ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 71 ARGENTINA ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 72 CHILE ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 73 CHILE ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 74 CHILE INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 75 CHILE ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 76 CHILE ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 77 CHILE IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 78 CHILE BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 79 CHILE IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 80 CHILE ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 81 CHILE ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 82 URUGUAY ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 83 URUGUAY ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 84 URUGUAY INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 85 URUGUAY ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 86 URUGUAY ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 87 URUGUAY IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 88 URUGUAY BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 89 URUGUAY IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 90 URUGUAY ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 91 URUGUAY ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 92 PERU ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 93 PERU ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 94 PERU INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 95 PERU ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 96 PERU ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 97 PERU IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 98 PERU BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 99 PERU IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 100 PERU ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 101 PERU ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 102 COLOMBIA ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 103 COLOMBIA ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 104 COLOMBIA INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 105 COLOMBIA ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 106 COLOMBIA ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 107 COLOMBIA IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 108 COLOMBIA BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 109 COLOMBIA IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 110 COLOMBIA ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 111 COLOMBIA ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 112 ECUADOR ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 113 ECUADOR ASSAY KITS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 114 ECUADOR INSTRUMENTS IN ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
TABLE 115 ECUADOR ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
TABLE 116 ECUADOR ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 117 ECUADOR IN-VIVO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 118 ECUADOR BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST) IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 119 ECUADOR IN-VITRO TEST IN ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
TABLE 120 ECUADOR ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 121 ECUADOR ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 122 REST OF LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES, 2018-2027 (USD MILLION)
List of Figure
FIGURE 1 LATAM ALLERGY DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 LATAM ALLERGY DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 LATAM ALLERGY DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 LATAM ALLERGY DIAGNOSTICS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 LATAM ALLERGY DIAGNOSTICS MARKET: C OMPANY RESEARCH ANALYSIS
FIGURE 6 LATAM ALLERGY DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 LATAM ALLERGY DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 THE VENDOR POSITIONING GRID ENABLES USERS OF DATA BRIDGE ANALYTICS TO GAUGE POTENTIAL MARKET GAPS AND UNDERSTAND THE REVENUE FLOW OF A MARKET.
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF LATAM ALLERGY DIAGNOSTICS MARKET
FIGURE 10 PREVALENCE OF ALLERGIC DISEASES PATIENTS IN THE UNITED ARAB EMIRATES, 2013–2015
FIGURE 11 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
FIGURE 12 LATAM ALLERGY DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 13 HIGH INCIDENCE OF ALLERGIC DISEASES AND RISING ENVIRONMENTAL POLLUTION LEVEL IS DRIVING THE LATAM ALLERGY DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 14 ASSAY KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE LATAM ALLERGY DIAGNOSTICS MARKET IN 2020 & 2027
FIGURE 15 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES, 2019
FIGURE 16 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)
FIGURE 17 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES, CAGR (2020-2027)
FIGURE 18 LATAM ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 19 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2019
FIGURE 20 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2018-2027 (USD MILLION)
FIGURE 21 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, CAGR (2020-2027)
FIGURE 22 LATAM ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, LIFELINE CURVE
FIGURE 23 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, 2019
FIGURE 24 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, 2018-2027 (USD MILLION)
FIGURE 25 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, CAGR (2020-2027)
FIGURE 26 LATAM ALLERGY DIAGNOSTICS MARKET, BY TEST, LIFELINE CURVE
FIGURE 27 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER, 2019
FIGURE 28 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER, 2018-2027 (USD MILLION)
FIGURE 29 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER, CAGR (2020-2027)
FIGURE 30 LATAM ALLERGY DIAGNOSTICS MARKET, BY END USER, LIFELINE CURVE
FIGURE 31 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019
FIGURE 32 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
FIGURE 33 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
FIGURE 34 LATAM ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 LATAM ALLERGY DIAGNOSTICS SNAPSHOT (2019)
FIGURE 36 LATAM ALLERGY DIAGNOSTICS: BY COUNTRY (2019)
FIGURE 37 LATAM ALLERGY DIAGNOSTICS: BY COUNTRY (2020 & 2027)
FIGURE 38 LATAM ALLERGY DIAGNOSTICS: BY COUNTRY (2019 & 2027)
FIGURE 39 LATAM ALLERGY DIAGNOSTICS: BY TREATMENT (2020 - 2027)
FIGURE 40 LATAM ALLERGY DIAGNOSTICS MARKET: COMPANY SHARE 2019 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
